COURAGE THERAPEUTICS, INC.
Newton, US · Delaware corporation · 1 known investors
Founders & leadership
DH
Daniel HousmanExecutive
RC
Roger ConeNamed on SEC filing
Board
IB
Isaac BarchasBoard director
BL
Bruce LeutcherBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$4.5M disclosed across 1 round · 2025
▶$4.5MraisedMay 2025 · 14 investors · BiotechnologyRule 506(b)
▶$4.5MraisedMay 2025 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Isaac BarchasDirector
- Roger ConeDirector
- Bruce LeutcherDirector
- Daniel HousmanExecutive Officer, Director
- Offering amount
- $10.5M
- Amount sold
- $4.5M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are COURAGE THERAPEUTICS, INC.'s investors?
- COURAGE THERAPEUTICS, INC.'s investors include Arsenal Bridge Venture.
- How much funding has COURAGE THERAPEUTICS, INC. raised?
- COURAGE THERAPEUTICS, INC. has disclosed $4.5M raised across 1 round.
- Where is COURAGE THERAPEUTICS, INC. headquartered?
- COURAGE THERAPEUTICS, INC. is headquartered in Newton, US.